United States Data πΊπΈ
Here is today's update regarding the spread of COVID-19 in the United States.- US Confirmed Cases: 374,754
- US Confirmed Deaths: 11,456
- US Death Rate: 3.1%
Based on today's number of confirmed cases and the current doubling period, here are today's projections if nothing changes and the doubling period remains constant:
- April 14 – 749,507 cases
- April 21 – 1.5 million cases
- April 28 – 3.0 million cases
- May 5 – 6.0 million cases
- April 11 – 23,000 deaths
- April 16 – 46,000 deaths
- April 20 – 92,000 deaths
- April 25 – 183,000 deaths
NOTE: You can click any chart above to see a larger version.
Global Data π
- Global Confirmed Cases: 1,385,323
- Global Confirmed Recovered: 125,875
- Global Confirmed Deaths: 78,973
- Global Death Rate: 5.7%
Based on today's cases and the current doubling period, here are the projections for the world if nothing changes and the doubling period remains constant:
- April 17 – 2.8 million cases
- April 28 – 5.5 million cases
- May 8 – 11.1 million cases
- May 19 – 22.2 million cases
Georgia Data π
These daily updates include data and projections for the state of Georgia because that is where a large number of my family and friends live.- Georgia Confirmed Cases: 8,818
- Georgia Cases Currently Hospitalized: 1,774 (20.1%)
- Georgia Confirmed Deaths: 329
- Georgia Death Rate: 3.7%
Based on today's number of confirmed cases and the current doubling period, here are today's projections if nothing changes and the doubling period remains constant:
- April 14 – 18,000 cases
- April 22 – 35,000 cases
- April 30 – 71,000 cases
- May 8 – 141,000 cases
Positive & Useful News
In an effort to provide some relief from the endless stream of scary news about COVID-19, these daily updates will include links to any available positive or constructive news related to this disease. Here are today's links:Treatments, Testing, and Vaccines
- Japan to offer anti-flu Avigan drug to 20 virus-hit nations for free
- Coronavirus Cure: Fujifilm Leads Japan’s Breakthrough
- Anti-Parasite Drug Ivermectin Stunts COVID-19 Virus Culture in Lab Study
- What Is Ivermectin? Head Lice Drug Appears to Stop Coronavirus—Here's What You Need to Know
- The latest scientific knowledge about Covid-19 symptoms and the global search for treatments
- Army researchers start coronavirus vaccine testing on primates at Maryland’s Fort Detrick
- Russia to Try Antiviral Drug Favipiravir as Coronavirus Treatment After 'Excellent Results' in China
- First Peer-Reviewed Coronavirus Vaccine Trial Shows Promising Results in Mice
- Walgreens to open 15 coronavirus drive-thru testing sites across 7 states
- Coronavirus in MS: Mississippi National Guard assists with testing
- US begins blood tests for coronavirus immunity: reports
- In war against coronavirus, researchers fast-track tests of Ebola drug
- Covid-19: 1.5mn doses of remdesivir ready for compassionate use, clinical trials
Medical and Protective Equipment for Healthcare Workers
- Vermont Glove retools to make masks
- Cummins, DuPont Partner to Supply Material for N95 Masks
- OSHA issues guidelines to conserve N95 masks
- Somerville N95 Decontamination Site Opens To Disinfect Up To 80,000 Masks A Day
- During COVID-19 Crisis, Medline Pivots To Sterilizing N95 Masks
- York General to use Ultraviolet light robot to sanitize N95 masks
- Military 3D-printing face shields, reusable N95 masks to address hospital shortages
- EPA donating 225,000 pieces of personal protective equipment to state and local governments
- PPE shielding us from COVID-19: Let's mass-produce face shields
Other News of Interest
- Your wearable might be an early warning system for viral illness
- Good news: Girl Scouts to continue cookie sales through COVID-19
- De Blasio cites potential good news amid otherwise daunting picture
- Cuomo Offers Some Good News in Terms of COVID-19 in New York
- Good news amid coronavirus: Delta donates 200,000 pounds of food
- Eleven Madison Park turned into a soup kitchen for New Yorkers in need
- A glimmer of hope in the Bay Area: New coronavirus cases slowing
No comments:
Post a Comment